Sonavex, Inc., a privately held medical device company focused on empowered patient care, announced today that on March 8, 2019 it received 510(k) clearance from the U.S. Food and Drug Administration for its EchoSure device to deliver definitive blood flow data on demand.
{iframe}https://www.prweb.com/releases/sonavex_receives_fda_510k_clearance_for_echosure/prweb16159077.htm{/iframe}